About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Scientific publications
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2003
2002
10
Nov 2022
02:30 E.S.T.
Efficient multitool/multiplex gene engineering with TALE-BE
Alex Boyne, Alexandre Juillerat, Sylvain Pulicani, Maria Feola, Diane Tkach, Robert Hong, Aymeric Duclert, Philippe Duchateau
Frontiers in Bioengineering and Biotechnology
Read more
30
Jun 2022
09:39 E.S.T.
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Julien Valton, Shipra Das, Siumin Jo
Nature Communications
Read more
28
Apr 2022
09:00 E.S.T.
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Roman Galetto, Agnès Gouble
Nature Communications
Read more
28
Apr 2022
08:56 E.S.T.
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Roman Galetto, Agnès Gouble
Nature Communications
Read more